≥99% HPLCPre-filled pen

TB500 + BPC157 Combo

Name: TB500 + BPC157 Combo
Brand: Dripfy
Availability: InStock

What it is?

TB500 + BPC-157 Combo is a stacked recovery protocol pairing two widely studied tissue-healing peptides. It is positioned to deliver synergistic regenerative signalling across vascular support, connective tissue remodelling, and inflammation balance, often selected when broader recovery coverage is required.

Dripfy Advantage

Synergistic repair signalling: Combines complementary mechanisms associated with regeneration, accelerating recovery dynamics in multi-tissue models.
Angiogenesis + tissue protection: Supports vascular signalling (perfusion/angiogenesis) alongside protective repair pathways relevant to injured tissue environments.
Connective tissue remodelling: Positioned for tendon, ligament, and joint repair markers via collagen and extracellular matrix (ECM) signalling support.
Inflammation modulation: May support a balanced inflammatory response, reducing prolonged inflammatory load while preserving repair signalling.
Protocol efficiency: Designed for streamlined recovery stacks where multiple endpoints (mobility, discomfort, repair kinetics) are targeted simultaneously.

Clinical Applications & Therapeutic Potential

Comprehensive tissue recovery: Positioned for multi-structure repair endpoints across muscle, tendon, ligament, and joint models.
Post-injury / post-surgical recovery: Potential support for faster recovery kinetics and earlier functional return markers (context-dependent).
Inflammation and mobility outcomes: Potential reductions in inflammation-associated markers with improved range-of-motion and mobility endpoints.
High-load training recovery: Often positioned for accelerated restoration in intensive training phases and repetitive-strain protocols.

Composition & Formulation

Peptide content: 5 mg TB-500 + 5 mg BPC-157
Vehicle: Proprietary pH-balanced buffer solution
Delivery system: Pre-filled, multi-dose, closed-system pen
Total volume: 3 mL
Purity: ≥99% for both peptides by HPLC/MS

€566

Order by email

Submit an enquiry and we arrange the consultation, physician review and shipping. Physician recommendation required; not medical advice.

Purity: ≥99%
Form: Pre-filled pen
Download Certificate of Analysis: Certificate of Analysis available on request

Important medical notice

A physician recommendation is mandatory before use.
The information on this website is educational only and is not medical advice, diagnosis, or treatment.
Always consult a qualified physician before starting any peptide.
Dosing is individualised and determined by your treating physician.

Peptide Practice Guide

Each card summarises what the peptide is studied for and its evidence strength. It is not a recommendation. Dosing and suitability are decided by your physician.

TB500 + BPC157 Combo

Investigational peptide combination (TB-500 + BPC-157), regenerative · Pre-filled pen

D· Preliminary evidence

This combination pairs two investigational tissue-repair peptides so that the cell-migration and angiogenic signalling associated with TB-500 sits alongside the growth-factor and cytoprotective signalling associated with BPC-157. The rationale is complementary coverage across vascular support, connective-tissue and extracellular-matrix (ECM) remodelling, and inflammation balance. The combination itself has not been validated in controlled human trials, and combining two unapproved agents can add rather than reduce uncertainty.

Studied use areas

Tendon, ligament and joint recovery (research context)
Broad multi-tissue recovery coverage
Angiogenesis combined with tissue protection
Connective-tissue and ECM remodelling
Inflammation balance during recovery

Safety & status

Combines two investigational, unapproved peptides; combined human safety data are absent
Interaction and additive-risk effects are not characterised
Both components are prohibited in competitive sport under the WADA prohibited list
Use only under qualified physician oversight

⚕ Clinical note: This card is educational and is not medical advice. This TB-500 + BPC-157 combination is investigational; any use must be individualised and determined by the treating physician.

Evidence: Investigational — no controlled human data on the combination; components are preclinical · References: peer-reviewed regenerative-medicine and preclinical tissue-repair literature; EMA/MHRA regulatory-status information on unapproved peptides; sports anti-doping (WADA) prohibited-substance listings